Shandong Boan Biotechnology Co., Ltd

6955 · HKEX

Public Market Listing

6955HKEX

HKEX primary exchange listing

Live quotes, historical charts, and market capitalization for Shandong Boan Biotechnology Co., Ltd are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(1 total)
1Total Assets
0Approved
0Phase 3 / Filed
1Phase 1–2 / Early
1Diseases
Showing 1 of 1 assets
Target & Modality
Phase 1
CD228 (melanotransferrin / MFI2, membrane-bound form)Antibody–drug conjugate
Non-Small Cell Lung Cancer

Upcoming events

No upcoming trial completions or earnings dates on record for this company's assets.

Financial reports

Annual history (2 years)

PeriodRevenueR&DCash & equiv.Net loss / qtrFiling
2025-FY$109M$11M——report ↗
View 1 more year
PeriodRevenueR&DCash & equiv.Net loss / qtrFiling
2024-FY$101M———report ↗